NetworkNewsBreaks – Mymetics (MYMX) Shares Skyrocket on Agreement with Sanofi for Flu Vaccines Research Project
Shares of Mymetics (OTCQB: MYMX) are up more than 400% after the company announced an agreement between its Mymetics B.V. subsidiary and Sanofi Pasteur, the vaccine division of Sanofi (NYSE: SNY). The two companies will start a research project to investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings. Mymetics said the successful completion of this project could result in an additional, more extensive collaboration with Sanofi in the future. To view the full press release, visit: http://nnw.fm/Guk0W About Mymetics Mymetics Corp. (OTCQB: MYMX) is a Swiss-based biotechnology company, with a Research Lab…







